Inventor · disambiguated record
Alexey L. Margolin
Also filed as: MARGOLIN ALEXEY · MARGOLIN ALEXEY L
26 granted patents·18 pending applications·484 citations·filing 1989–2024
96Inventor score
Files withALCRESTA THERAPEUTICS INC15ALTUS BIOLOGICS INC7ALTUS PHARMACEUTICALS INC5ANAGRAM THERAPEUTICS INC3MARGOLIN ALEXEY L3
Top patents by PatentIndex Score
44 records- 0195US6541606B2Stabilized protein crystals formulations containing them and methods of making themALTUS BIOLOGICS INC·Filed 1999·Granted Apr 1, 2003·178 cites·22 claims
- 0294US6140475AControlled dissolution crosslinked protein crystalsALTUS BIOLOGICS INC·Filed 1997·Granted Oct 31, 2000·80 cites·19 claims
- 0394US2025134779A1Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0493US9668942B2Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2013·Granted Jun 6, 2017·13 cites·31 claims
- 0593US2024350370A1Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0693US2024350369A1Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0791US12178785B2Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2023·Granted Dec 31, 2024·0 cites·30 claims
- 0891US7833525B2Crystals of whole antibodies and fragments thereof and methods for making and using themSHENOY BHAMI·Filed 2001·Granted Nov 16, 2010·55 cites·41 claims
- 0990US7351798B2Stabilized protein crystals, formulations comprising them and methods of making themALTUS PHARMACEUTICALS INC·Filed 2003·Granted Apr 1, 2008·37 cites·8 claims
- 1089US7718169B2Compositions and methods for treating pancreatic insufficiencyCYSTIC FIBROSIS FOUNDATIONS TH·Filed 2005·Granted May 18, 2010·68 cites·20 claims
- 1187US12178784B2Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2022·Granted Dec 31, 2024·0 cites·26 claims
- 1287US12059391B2Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2022·Granted Aug 13, 2024·0 cites·29 claims
- 1387US11998511B2Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2022·Granted Jun 4, 2024·0 cites·18 claims
- 1486US10987280B2Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2018·Granted Apr 27, 2021·0 cites·12 claims
- 1586US10828239B2Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2018·Granted Nov 10, 2020·0 cites·37 claims
- 1683US11872191B2Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2021·Granted Jan 16, 2024·0 cites·21 claims
- 1781US10632047B2Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2017·Granted Apr 28, 2020·1 cites·18 claims
- 1880US7087728B2Carbohydrate crosslinked glycoprotein crystalsALTUS PHARMACEUTICALS INC·Filed 2002·Granted Aug 8, 2006·10 cites·7 claims
- 1979US7459155B2Treating abdominal pain due to pancreatitis with seaproseALTUS PHARMACEUTICALS INC·Filed 2004·Granted Dec 2, 2008·10 cites·58 claims
- 2078US6500933B1Methods of preparing carbohydrate crosslinked glycoprotein crystalsALTUS BIOLOGICS INC·Filed 2000·Granted Dec 31, 2002·8 cites·13 claims
- 2176US8558048B2Stabilized protein crystals, formulations comprising them and methods of making themMARGOLIN ALEXEY L·Filed 2009·Granted Oct 15, 2013·3 cites·7 claims
- 2276US2025243475A1Methods and compositions for treating congenital sucrase-isomaltase deficiencyANAGRAM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2368US9775784B2Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2017·Granted Oct 3, 2017·0 cites·26 claims
- 2468US9775783B2Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2017·Granted Oct 3, 2017·0 cites·23 claims
- 2566US9687420B2Methods, compositions, and devices for supplying dietary fatty acid needsALCRESTA THERAPEUTICS INC·Filed 2016·Granted Jun 27, 2017·0 cites·24 claims
- 2663US2024392270A1Engineered lipase enzymes, manufacture and use thereofANAGRAM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2762US2008226623A1Stabilized protein crystals, formulations comprising them and methods of making themALTUS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2860US9310379B2Methods of crystallizing antibodiesSHENOY BHAMI·Filed 2008·Granted Apr 12, 2016·0 cites·12 claims
- 2960US2003211127A1Controlled dissolution crosslinked prote in crystalsFiled 2003·Application pending·0 cites
- 3059US2014086988A1Stabilized Protein Crystals, Formulations Containing Them and Methods of Making ThemALTHEA TECHNOLOGIES INC·Filed 2013·Application pending·0 cites
- 3158US2009081184A1Non-pancreatic proteases for controlling plasma cholecystokinin (cck) concentration and for treating painALTUS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3257US2006128587A1Lipase-containing composition and methods of use thereofALTUS BIOLOGICS INC·Filed 2005·Application pending·0 cites
- 3356US6359118B2Carbohydrate crosslinked glycoprotein crystalsALTUS BIOLOGICS INC·Filed 1999·Granted Mar 19, 2002·16 cites·24 claims
- 3456US2024350594A1Methods and compositions for treating hyperglycemia and diabetesANAGRAM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3554US2006104935A1Controlled dissolution crosslinked protein crystalsMARGOLIN ALEXEY L·Filed 2006·Application pending·0 cites
- 3653US2002137899A1Carbohydrate crosslinked glycoprotein crystalsALTUS BIOLOGICS INC·Filed 2002·Application pending·0 cites
- 3751US11077238B2Compositions, methods, and devices for dialysisALLENA PHARMACEUTICALS INC·Filed 2014·Granted Aug 3, 2021·0 cites·9 claims
- 3848US4970317AProcess for the preparation of castanospermine estersMERRELL DOW PHARMA·Filed 1989·Granted Nov 13, 1990·4 cites·6 claims
- 3947US2004202643A1Controlled dissolution crosslinked protein crystalsALTUS BIOLOGICS INC·Filed 2004·Application pending·0 cites
- 4041US2008311101A1Method to Reduce Oxalate Concentration by Administration of Oxalate Oxidase CrystalsSHENOY BHAMI C·Filed 2006·Application pending·0 cites
- 4137US2010196344A1Compositions and methods for treating pancreatic insufficiencyCYSTIC FIBROSIS FOUNDATION THE·Filed 2010·Application pending·0 cites
- 4236US5316944AEnzymatic resolution of a racemic mixture of gamma-amino acids using penicillin acylaseMERRELL DOW PHARMA·Filed 1992·Granted May 31, 1994·1 cites·4 claims
- 4331US2006223156A1Controlled dissolution crosslinked protein in crystalsMARGOLIN ALEXEY L·Filed 2005·Application pending·0 cites
- 4431US2002137156A1Controlled dissolution crosslinked protein crystalsFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →